MARKET ACCESS IN CENTRAL AND EASTERN EUROPE- WHAT ARE THE DRIVERS AND CHALLENGES?

Author(s)

Oresta Piniazhko, PhD, President, Ministry of Health of Ukraine, Lviv, Ukraine; Bertalan Ne+L123meth, MSc, President, Syreon Research Institute, Budapest, Hungary; Joanna Lis, PhD, Assistant Professor, Sanofi, Warsaw, Poland; Vladimir Zah, PhD, Visiting Professor, Kozminski University, Warsaw Poland and Health Economist, CEO, ZRx Outcomes Research Inc., Serbia, Belgrade, Serbia; Olha Zaliska, PhD, DSci, Professor, Head of the Department of Management and Economy of Pharmacy, Drug Technology and Pharmacoeconomics, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

What are the latest trends in CEE market access demonstrating value? Are they ensuring patients access to lifesaving and innovative health technologies? Is there a place to managed entry agreements and what new approaches are applied to pricing solutions and reimbursement programs? Participants of this interactive Forum will discuss vision towards the market access environment, strategic plan, and how to optimise access and value of innovative medicines in CEE. Interactive participation by the audience is anticipated.

Conference/Value in Health Info

2018-11, ISPOR Europe 2018, Barcelona, Spain

Code

F3

Topic

Health Policy & Regulatory

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×